Our Pipeline

AskGene’s pipeline is composed of several biosimilar candidates and discovery programs built around the most advanced technology platforms, in both human and animal applications.


  • 2017.6 AskGene and Aosaikang submit the IND package of ASK965 to CFDA.
  • 2017.5 AskGene/Aosaikang collaborates with Wuxi biologics for ASK1202 phase I clinical material production.
  • 2017.3 AskGene/Aosaikang gains clinical approval for its ASK1202 project.
  • 2016.8 AskGene submit the IND briefing package to EMA.
  • 2016.8  AskGene/Aosaikang submit the IND package of ASK-B1202 to CFDA